Early-Onset Menopause Tied to Increased CVD Events, Mortality

This article originally appeared here.
Share this content:
Early-Onset Menopause Tied to Increased CVD Events, Mortality
Early-Onset Menopause Tied to Increased CVD Events, Mortality

THURSDAY, Sept. 15, 2016 (HealthDay News) -- Women who enter menopause early may be at greater risk for cardiovascular disease and premature death, according to a review published online Sept. 14 in JAMA Cardiology.

Taulant Muka, M.D., Ph.D., of the Erasmus University Medical Center in Rotterdam, Netherlands, and colleagues reviewed 32 studies involving 310,329 women. The investigators compared women who were younger than 45 at the start of menopause with those who were aged 45 and older when it began.

Overall, cardiovascular disease risk appeared to be 50 percent greater for the women who were under 45 when menopause began. Early menopause also appeared to increase risk of cardiovascular death and death from all causes. There was no apparent association with stroke risk.

While early menopausal women faced increased cardiovascular and premature death risks, women aged 50 to 54 at the onset had a lower risk of fatal cardiovascular disease than women younger than 50. Based on the findings, "age at menopause might be a predictor of future cardiovascular events and mortality in postmenopausal women," Muka told HealthDay.

The study was sponsored and funded by Metagenics, a California-based maker of nutritional supplements.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »